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INTRODUCTION
The COVID-19 pandemic in 2019 has 
spread from Wuhan China and now spread 
worldwide and become an international pan-
demic (Zhu et al., 2020). The disease can lead 
to severe respiratory illness following an incu-
bation time of 2-14 days (Backer et al., 2020). 
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Abstract. The COVID-19 has spread worldwide and become an
international pandemic. The promising target for drug discovery of 
COVID-19 was SARS-CoV-2 Main Protease (Mpro), that has been 
successfully crystallized along with its inhibitor. The discovery of
peptide-based inhibitors may present better options than small
molecules for inhibitor SARS-CoV-2 Mpro. Natural compounds have 
such a wide potential and still few explored, Ziziphus spina-christi
is one of the medicinal plants that have many pharmacological
activities and contains a peptide compound from alkaloids class, 
i.e. cyclopeptide alkaloids, that is interesting to explore as SARS-
CoV-2 Mpro inhibitor. The compound structure was drawn and opti-
mized using density functional theory 3-21G method. The protein 
chosen was the high resolution of SARS-CoV-2 Mpro receptor (1.45 
Å) with PDB ID: 6WNP, in complex with Boceprevir. Molecular 
docking simulation was performed using AutoDock 4.2 with 100 num-
bers of GA run, the validation methods assessed by RMSD calcula-
tion. Furthermore, the prediction of pharmacological activity spectra 
was carried out using the PASS Prediction server. The results showed 
RMSD value was 1.98 Å, this docking method was valid. The binding
energy of all compounds showed better results than the native ligand 
(Boceprevir). The in silico PASS prediction results indicated that 
all compounds showed antiviral activity. Some compounds showed 
protease inhibitory activity, i.e Ambiphibine-H, Franganine, and 
Mauritine-A, and the highest Pa (Predicted activity) value showed 
by Mauritine-A compounds. It can be concluded that the cyclo
peptide compounds of Ziziphus spina-christi were indicated to have 
a potential as COVID-19 therapy targeting SARS-CoV-2 Mpro.
Keywords: COVID-19, in silico, peptide alkaloids, SARS-CoV-2 main 
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In the present situational report from WHO, 
released on November 6th, 2020, there are 
48,534,508 COVID-19 confirmed cases and 
1,231,017 confirmed death globally (World 
Health Organization, 2020). 
One of the promising targets for drug 
discovery of COVID-19 was SARS-CoV-2 
Main Protease (Mpro), which has been ob-
tained its crystal structure along with its in-
hibitors (Jin et al., 2020; Khaerunnisa et al., 
2020; Mirza & Froeyen, 2020; Reiner et al., 
2020). The main protease in COVID-19 is 
not the same as in humans and is the key en-
zyme of the viral replication cycle (Goyal & 
Goyal, 2020; Gurung et al., 2020; Ullrich & 
Nitsche, 2020). The peptide-like anti-HIV-1 
drugs are effective against SARS-CoV Main 
protease (Mpro). Due to the close phylo-
genetic relationship between SARS-CoV and 
SARS-CoV-2, many of their main proteases 
resemblant in structural and functional fea-
tures (Rut et al., 2020; Yoshino et al., 2020). 
So, the discovery of peptide-based inhibitors 
may present better options than small mole-
cules for COVID-19 therapy (Du et al., 2007; 
Han & Král, 2020). 
Natural compounds have broad poten-
tial which can still be explored (Dias et al., 
2012). So our oriented towards treatments 
of natural product compounds based on pep-
tide-like from medicinal plants in order to 
obtain compounds having the ability to in-
hibit COVID-19 (Benarba & Pandiella, 2020; 
Khare et al., 2020). One of the medicinal 
plants and has peptide compounds we chose 
for this research, i.e. Ziziphus spina-christi 
species (Darusman & Fakih, 2020). 
Ziziphus spina-christi is a deciduous 
tree that generally comes from warm and sub-
tropical climates region, such as North Africa, 
South Europe, Mediterranean, tropical Ame-
rica, South and East of Asia, and others, in-
cluding Indonesia (Yossef et al., 2011). There 
are many names for Z. spina-christi, which 
is known as the thorn of Christ; Syria Christ-
thorn in English, on behalf of epine (Saied 
et al., 2008). Z. spina-christi is also a plant 
mentioned in the Holy Qur'an, the holy book 
of Islam, as a plant that has many medicinal 
benefits (Ishrak et al., 2006).
Ziziphus spina-christi has been proven 
and reported to have various pharmacological 
activities, including antibacterial, antifungal, 
antioxidant, antihyperglycemic, and anti-
nociceptive, etc. Flavonoids, alkaloids, and
saponins are the main phytochemicals repor-
ted from this plant (Asgarpanah, 2012). The
Z. spina-christi has several peptide com-
pounds in the alkaloids class, i.e. cyclopeptide
alkaloids, that have been reported, can be 
found in stem-bark (Inayat-ur-Rahman et al., 
2001). 
By looking at the potential of the pep-
tide type compounds that were reported to be 
the most potent inhibitors of the main pro-
tease enzyme of SARS-CoV-2, and also the
alkaloid peptide content in the Z. spina-christi
plant which has not been explored for its
activity through SARS-CoV-2 Mpro, So we 
interested to investigate the potency of cyclo-
peptide alkaloids from Z. spina-christi as an 
inhibitor of SARS-CoV-2 Mpro.
MATERIALS AND METHODS
The experiment was carried out on
October-December 2020, at the Laboratory 
of Pharmaceutical Chemistry, Department 
of Pharmacy, Faculty of Mathematics and
Natural Sciences, Universitas Islam Bandung, 
Bandung, Indonesia.
Hardware and Software
This research was conducted using
hardware in the form of computers and 
HPC (High-Performance Computing) facili-
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ties owned by the Department of Pharmacy,
Faculty of Mathematics and Natural Sciences,
Universitas Islam Bandung. The computer is 
equipped with software with Windows 7 and
Linux Ubuntu 16.04 operating systems 
equipped with Quantum ESPRESSO
v.6.6, MGL Tools 1.5.6 with AutoDock 4.2,
Prediction of Activity Spectra for Substances 
(PASS) web server, and BIOVIA Discovery 
Studio Visualizer 2020.
Ligand Preparation
The 3D ligand structures were drawn 
and optimized using Density Functional
Theory (DFT)  methods with a 3-21G basis 
set using Quantum ESPRESSO v.6.6. The
ligands chose were bioactive compounds that 
contained in Ziziphus species i.e. Amphibine
-H, Franganine, Jubanine-A, Mauritine-A, 
Sativanine-B, and Zizyphine-F. These pep-
tide compounds are reported found in the
Ziziphus spina-christi plant. The structure of 




Figure 1. Chemical structure of Amphibine-H (A); Franganine (B); Jubanine-A (C); Mauritine-A (D); 
Sativanine-B (E); and Zizyphine-F (F).
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Reseptors Preparation
The crystallography structures of 
SARS-CoV-2 Mpro were obtained from the 
Protein Data Bank (PDB) (http://www.rcsb.
org/pdb/). The high resolution of the SARS-
CoV-2 Mpro receptor (1.45 Å) with PDB 
ID: 6WNP was chosen. The 6WNP was cho-
sen because of its high resolution compared 
to other types of SARS-CoV-2 Mpro crystal 
protein in PDB. The receptor was complexed 
with Boceprevir an HCV protease inhibitor as 
a co-crystal ligand. Furthermore, the unique 
ligands and water molecules were removed 
from the receptor. Then, polar hydrogen and 
a charge (Kollman charge) was added to the 
receptor structure. All preparation procedures 
were performed using MGLTools 1.5.6. with 
AutoDock 4.2 (Morris et al., 2010).
In Silico PASS Prediction
The in silico Prediction of Activity 
Spectra for Substances (PASS) was carried 
out to get biological activity spectra of com-
pounds accessed through PASS web server 
(http://www.way2drug.com/PASSOnline/pre-
dict.php) (Lagunin et al., 2000). The predic-
ted spectrum as probable activity (Pa) and pro-
bable inactivity (Pi) that was estimated based 
on structure-activity relationship analysis of 
the training set containing more than 205,000 
compounds exhibiting more than 3750 kinds 
of biological activities. Being probabilities, 
the Pa and Pi values vary from 0.000 to 1.000. 
The PASS prediction was interpreted and used 
in a flexible manner: (i) only activities with Pa 
> Pi are considered as possible for a particu-
lar compound; (ii) if Pa >0.7, the chance to 
find activity is experimentally high; (iii) if Pa 
is >0.5 but less than <0.7, the chance to find 
activity is experimentally low, but the com-
pound is probably different to known pharma-
ceutical agents; (iv) if Pa <0.5, the chance to 
find activity is experimentally is low, but the 
chance to find new chemical entities is high 
(Anzali et al., 2001).
Molecular Docking Simulation
The co-crystal ligand was re-docked on 
the binding pocket of the protein to valida-
ted the docking method. The best confor-
mation of the co-crystal ligand was taken 
and superimposed with the co-crystal ligand
before docked, and the Root-Mean-Square 
Deviation (RMSD) was assessed. The
acceptable RMSD value must be less than 
2.0 Å (Bell & Zhang, 2019). Furthermore, 
we docked all of the ligands to the binding 
pocket of the SARS-CoV-2 Mpro. The grid 
box was set with coordinates 7.579, 26.283, 
and 23.017 (x, y, and z), and the dimensions 
of the grid box were 64, 60, and 60 (x, y, and 
z), and 100 numbers of GA run. Furthermore, 
the conformation of each ligand was analyzed 
for binding energy and amino acid interaction.
RESULTS AND DISCUSSION
In Silico PASS Prediction
PASS prediction was carried out on 
Boceprevir, and cyclopeptide alkaloids com-
pound to see and compare their probability 
level as a COVID-19 main protease inhibitor 
(Table 1). Boceprevir was predicted to have 
activity as an antiviral and protease inhibitor, 
with Pa values of 0.730 and 0.347, respective-
ly. The cyclopeptide alkaloids compounds, 
Ambiphine-H, Franganine, Jubanine-A, 
Mauritine-A, Sativanine-B, and Zizyphine-F,
showed antiviral activity with Pa values 
of  0.263, 0.201, 0.203, 0.277, 0.162, and 
0.300, respectively. Protease inhibitor activity
predicted by Ambiphine-H (Pa 0.118),
Franganine (Pa 0.097), and Mauritine-A (Pa 
0.131) compounds. Overall, all compounds 
showed potency as antiviral activity and 
some as a protease inhibitor, and Mauritine-A 
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compounds showed the best results of PASS 
prediction as antiviral and protease inhibitor.
Molecular Docking Simulation
Validation was carried out to see the 
strength of binding mode prediction through 
re-docking the co-crystal ligand into its bin-
ding site. It showed that the RMSD value of 
the co-crystal ligand was 1.069 Å. The RMSD 
value below 2.0 Å shows that the molecular 
docking method used is valid. The overlay of 
the docked co-crystal ligand and docked boce-
previr can be seen in Figure 2. The cyclo-
peptide alkaloids after docked showed varied 
binding energies (Table 2). In general, the cy-
clopeptide alkaloids of Ziziphus spina-christi 
from the docking results, showed high bind-
ing energy and Ki compared to the co-crystal 
ligand. The negative sign or the lowest bind-
ing energy is considered to be stable to inte-
ract with receptors (Ramadhan et al., 2020). 
The binding energy of the co-crystal ligand 
was −7.93 Kcal/mol. The cyclopeptide alka-
loids binding energy sort by highest to lowest 
were –9.88 Kcal/mol (Mauritine-A), −9.12 
Kcal/mol (Amphibine-H), −8.98 Kcal/mol
(Sativanine-B), −8.61 Kcal/mol (Jubanine-A), 
−8.08 Kcal/mol (Zizyphine-F), and –7.97 
Kcal/mol (Franganine).
Figure 2. The overlay of the co-crystal (green) and 
docked (red) conformation of Boceprevir
Ligands Activities prediction Pa Pi
Boceprevir
Antiviral 0.730 0.004
Protease inhibitor 0.347 0.006
Ambiphibine-H
Antiviral 0.263 0.052
Protease inhibitor 0.118 0.070
Franganine
Antiviral 0.201 0.095
Protease inhibitor 0.097 0.092
Jubanine-A
Antiviral 0.203 0.093
Protease inhibitor - -
Mauritine-A
Antiviral 0.277 0.045
Protease inhibitor 0.131 0.060
Sativanine-B
Antiviral 0.162 0.146
Protease inhibitor - -
Zizyphine-F
Antiviral 0.300 0.037
Protease inhibitor - -
Table 1. In silico PASS prediction results
Pa: Probable activity, Pi: Probable inactivity
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Molecular Interactions
The amino acid interactions of cyclo-
peptide alkaloids with the SARS-CoV-2 
Mpro were observed and compared to refe-
rence co-crystal ligand (Boceprevir) binding 
mode. The tabulation data of the interactions 
is presented in Table 3 and the 2D interaction 
can be seen in Figure 3. Co-crystal ligand in 
its interactions, form hydrogen bonds with 
amino acids Glu:166, His:163, Leu:141, and 
Cys:145. Co-crystal ligand also forms sever-
al types of pi interaction with His:41 (pi-sig-
ma and pi-alkyl) and alkyl interaction with 
Met:165 and Met:49. The cyclopeptide al-
kaloids in SARS-CoV-2 Mpro showed rich-
er interaction than co-crystal ligand, but the 
types of bonds formed are slightly different. 
Amphibine-H showed 5 similar residues, i.e. 
Glu:166, His:163, Cys:145, His:41, Met:49, 
and 3 different residues, i.e. Gly:143, Leu:27, 
and Phe:140. Franganine showed 5 simi-
lar residues, i.e. Glu:166, His:163, Cys:145, 
His:41, Met:49, and 3 different residues, i.e. 
Pro:168, Gln:189, and Arg:188. Jubanine-A 
showed 4 similar residues, i.e. Glu:166, 
His:41, Met:165, and Met:49, and 1 different 
residue, i.e. Arg:188. Mauritine-A showed 3 
similar residues, i.e. Glu:166, His:41, Met:49, 
and Met:49, and 2 different residues, i.e. 
Arg:188, and Phe:140. Sativanine-B showed 
4 similar residues, i.e. His:163, Cys:145, 
His:41, Met:165, and 1 different residue, i.e. 
Arg:188, and His:164. Zizyphine-F showed 
3 similar residues, i.e. Glu:166, His:41, 
Met:165, and 6 different residues, i.e. His:164, 
Gln:189, Pro:168, Leu:167, and Arg:188.
The hydrogen bond is a bond between 
an H partial positive charge atom with other 
nearby electronegative atoms and has lone 
pairs of free electrons that have a complete 
octet, such as O, N, and F, and is the stron-
gest non-bond interaction of ligand-receptor 
(Megantara et al., 2017). Co-crystal ligand 
still shows the highest intensity of hydro-
gen bonding (4 hydrogen bonds), followed 
by Sativanine-B (3 hydrogen bonds), and 
Ampibhine-H, Jubanine-A, Mauritine-A, 
and Zizyphine-F (2 hydrogen bonds, respec-
tively). The other interactions, i.e. Pi-sigma, 
Pi-alkyl, and Pi-Sulfur, etc., mostly involve 
charge transfer assisting in intercalating the 
drug at the receptor-binding site. The highest 
number of amino acid interactions that form 
Pi interaction are dominated by Zizyphine-F, 
then Amphibine-H, Franganine, Sativanine-B, 
Mauritine-A, and Jubanine-A, respectively.









Table 2. Binding energy of the cyclopeptide alkaloids of Ziziphus spina-christi to 
the SARS-CoV-2 Mpro receptor
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Figure 3. Two-dimensional interactions of co-crystal ligand (A), Amphibine-H (B), Franganine (C), 
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Synthetic peptides have been extensive-
ly researched and proven to be able to inhibit 
the activity of the SARS-CoV-2 Mpro enzyme, 
however, peptides from natural compounds 
are still lacking in exploration while their 
potential is still very wide. One of the plants 
known to contain metabolites in the form 
of peptides which are classified as alkaloids 
group, e.g. cyclopeptide alkaloids, is Ziziphus 
spina-christi. In this study we tried to predict
whether the cyclopeptide alkaloids from
Ziziphus spina-christi have potential as an
antiviral for SARS-CoV-2, specific to the main 
protease receptor, using the in silico method. 
This research revealed that cyclopeptide alka-
loids from Ziziphus spina-christi species have 
potential as inhibitor candidates for the SARS-
CoV-2 Mpro receptor. This is supported by 
the activity prediction results, In silico PASS 
prediction, that showed all cyclopeptide alka-
loid compounds have antiviral activity and 
some compounds showed protease inhibitory 
activity, i.e Ambiphibine-H, Franganine, and 
Mauritine-A. The highest Pa value (Predicted 
Table 3. Data of amino acid interactions of reference ligand (co-crystal ligand) compared to cyclo peptide alkaloids 
in SARS-CoV-2 Mpro
a: conventional hydrogen-bond, b: pi-sigma, c: pi-alkyl, d: alkyl, e: pi-sulfur, f: pi-pi T-shaped, g: carbon-hydrogen 
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activity) showed by Mauritine-A compounds. 
Further, the molecular docking of Amphi-
bine-H, Franganine, Jubanine-A, Mauritine-A, 
Sativanine-B, and Zizyphine-F, showed better 
binding affinity against SARS-CoV-2 Mpro 
compared to co-crystal ligand (Boceprevir). 
These compounds form interactions that are 
similar in some residues with the co-crystal 
ligand. It is suspected that the large binding 
energy of these ligands is due to the amino 
acid interactions, which are more numerous 
than Boceprevir. Where it is known, the num-
ber of amino acid interactions will affect the 
bond strength of the ligand to the active site 
of the receptor.
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